Symbol:
Ifi35
Name:
interferon-induced protein 35
RGD ID:
1304553
Description:
Predicted to enable identical protein binding activity. Predicted to be involved in several processes, including macrophage activation involved in immune response; positive regulation of defense response; and regulation of non-canonical NF-kappaB signal transduction. Predicted to be located in several cellular components, including cytosol; extracellular space; and nuclear lumen. Predicted to be active in nucleus. Orthologous to human IFI35 (interferon induced protein 35); INTERACTS WITH (+)-schisandrin B; 2,3,7,8-tetrachlorodibenzodioxine; bisphenol A.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
LOC287719; MGC108976
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
IFI35 (interferon induced protein 35) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Ifi35 (interferon-induced protein 35) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Ifi35 (interferon induced protein 35) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
IFI35 (interferon induced protein 35) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
IFI35 (interferon induced protein 35) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ifi35 (interferon induced protein 35) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
IFI35 (interferon induced protein 35) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
IFI35 (interferon induced protein 35) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Ifi35 (interferon induced protein 35) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
IFI35 (interferon induced protein 35)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Ifi35 (interferon-induced protein 35)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ifi35 (interferon-induced protein 35)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
ifi35
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 86,881,270 - 86,889,523 (+) NCBI GRCr8 mRatBN7.2 10 86,381,023 - 86,389,279 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 86,381,010 - 86,389,952 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 91,418,433 - 91,426,447 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 90,893,398 - 90,901,717 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 86,286,702 - 86,295,023 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 89,358,376 - 89,366,628 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 89,358,376 - 89,366,626 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 89,156,392 - 89,164,644 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 90,475,323 - 90,483,575 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 90,489,692 - 90,497,943 (+) NCBI Celera 10 85,098,510 - 85,106,762 (+) NCBI Celera Cytogenetic Map 10 q31 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ifi35 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IFI35 mRNA] CTD PMID:31150632 Ifi35 Rat 1,2-dimethylhydrazine increases expression ISO Ifi35 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of IFI35 mRNA CTD PMID:22206623 Ifi35 Rat 1,2-dimethylhydrazine multiple interactions ISO Ifi35 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of IFI35 mRNA] CTD PMID:22206623 Ifi35 Rat 17beta-estradiol increases expression ISO IFI35 (Homo sapiens) 6480464 Estradiol results in increased expression of IFI35 mRNA CTD PMID:21185374 Ifi35 Rat 17beta-estradiol decreases expression ISO Ifi35 (Mus musculus) 6480464 Estradiol results in decreased expression of IFI35 mRNA CTD PMID:39298647 Ifi35 Rat 17beta-estradiol multiple interactions ISO IFI35 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of IFI35 mRNA CTD PMID:30165855 Ifi35 Rat 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Ifi35 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 Ifi35 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IFI35 mRNA CTD PMID:21215274 and PMID:32109520 Ifi35 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ifi35 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IFI35 mRNA CTD PMID:21570461 Ifi35 Rat 4,4'-sulfonyldiphenol increases expression ISO Ifi35 (Mus musculus) 6480464 bisphenol S results in increased expression of IFI35 mRNA CTD PMID:30951980 and PMID:39298647 Ifi35 Rat 5-fluorouracil increases expression ISO IFI35 (Homo sapiens) 6480464 Fluorouracil results in increased expression of IFI35 mRNA CTD PMID:16101138 Ifi35 Rat 6alpha-methylprednisolone decreases expression ISO IFI35 (Homo sapiens) 6480464 Methylprednisolone results in decreased expression of IFI35 mRNA CTD PMID:19192274 Ifi35 Rat actinomycin D multiple interactions ISO IFI35 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of IFI35 mRNA CTD PMID:38460933 Ifi35 Rat all-trans-retinoic acid increases expression ISO IFI35 (Homo sapiens) 6480464 Tretinoin results in increased expression of IFI35 mRNA CTD PMID:15498508 and PMID:33167477 Ifi35 Rat aluminium atom decreases expression ISO Ifi35 (Mus musculus) 6480464 Aluminum results in decreased expression of IFI35 mRNA CTD PMID:37544489 Ifi35 Rat aluminium(0) decreases expression ISO Ifi35 (Mus musculus) 6480464 Aluminum results in decreased expression of IFI35 mRNA CTD PMID:37544489 Ifi35 Rat aristolochic acid A decreases expression ISO IFI35 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of IFI35 mRNA CTD PMID:33212167 Ifi35 Rat azathioprine decreases expression ISO IFI35 (Homo sapiens) 6480464 Azathioprine results in decreased expression of IFI35 mRNA CTD PMID:19192274 Ifi35 Rat benzo[a]pyrene increases expression ISO Ifi35 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of IFI35 mRNA CTD PMID:23735875 Ifi35 Rat bisphenol A increases expression ISO IFI35 (Homo sapiens) 6480464 bisphenol A results in increased expression of IFI35 mRNA CTD PMID:29275510 Ifi35 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IFI35 mRNA CTD PMID:30816183 more ... Ifi35 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IFI35 mRNA CTD PMID:25181051 Ifi35 Rat bisphenol F increases expression ISO Ifi35 (Mus musculus) 6480464 bisphenol F results in increased expression of IFI35 mRNA CTD PMID:30951980 Ifi35 Rat calcitriol increases expression ISO IFI35 (Homo sapiens) 6480464 Calcitriol results in increased expression of IFI35 mRNA CTD PMID:21592394 Ifi35 Rat calcitriol multiple interactions ISO IFI35 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of IFI35 mRNA CTD PMID:21592394 Ifi35 Rat camptothecin increases expression ISO IFI35 (Homo sapiens) 6480464 Camptothecin results in increased expression of IFI35 mRNA CTD PMID:38460933 Ifi35 Rat carbon nanotube increases expression ISO Ifi35 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Ifi35 Rat chlordecone affects response to substance ISO IFI35 (Homo sapiens) 6480464 IFI35 gene SNP affects the susceptibility to Chlordecone CTD PMID:25622337 Ifi35 Rat chromium(6+) affects expression ISO Ifi35 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of IFI35 mRNA CTD PMID:28472532 Ifi35 Rat cisplatin multiple interactions ISO IFI35 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of IFI35 mRNA CTD PMID:27392435 Ifi35 Rat cisplatin increases expression ISO IFI35 (Homo sapiens) 6480464 Cisplatin results in increased expression of IFI35 mRNA CTD PMID:27392435 Ifi35 Rat cyclosporin A increases expression ISO IFI35 (Homo sapiens) 6480464 Cyclosporine results in increased expression of IFI35 mRNA CTD PMID:20106945 more ... Ifi35 Rat cyclosporin A decreases expression ISO IFI35 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of IFI35 mRNA CTD PMID:25562108 Ifi35 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of IFI35 mRNA CTD PMID:21266533 Ifi35 Rat diclofenac decreases expression ISO IFI35 (Homo sapiens) 6480464 Diclofenac results in decreased expression of IFI35 mRNA CTD PMID:19192274 Ifi35 Rat dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of IFI35 mRNA CTD PMID:34051100 Ifi35 Rat dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI35 mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI35 mRNA CTD PMID:33729688 Ifi35 Rat doxorubicin decreases expression ISO IFI35 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of IFI35 mRNA CTD PMID:29803840 Ifi35 Rat elemental selenium increases expression ISO IFI35 (Homo sapiens) 6480464 Selenium results in increased expression of IFI35 mRNA CTD PMID:19244175 Ifi35 Rat ethyl methanesulfonate increases expression ISO IFI35 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of IFI35 mRNA CTD PMID:23649840 Ifi35 Rat folic acid multiple interactions ISO Ifi35 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of IFI35 mRNA] CTD PMID:22206623 Ifi35 Rat folic acid increases expression ISO Ifi35 (Mus musculus) 6480464 Folic Acid deficiency results in increased expression of IFI35 mRNA CTD PMID:32304770 Ifi35 Rat Genipin multiple interactions ISO Ifi35 (Mus musculus) 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA] CTD PMID:22687549 Ifi35 Rat glycidyl methacrylate decreases expression ISO IFI35 (Homo sapiens) 6480464 glycidyl methacrylate results in decreased expression of IFI35 protein CTD PMID:36641056 Ifi35 Rat isotretinoin increases expression ISO IFI35 (Homo sapiens) 6480464 Isotretinoin results in increased expression of IFI35 mRNA CTD PMID:20436886 Ifi35 Rat ivermectin decreases expression ISO IFI35 (Homo sapiens) 6480464 Ivermectin results in decreased expression of IFI35 protein CTD PMID:32959892 Ifi35 Rat lead diacetate decreases expression ISO Ifi35 (Mus musculus) 6480464 lead acetate results in decreased expression of IFI35 mRNA CTD PMID:20542052 Ifi35 Rat lipopolysaccharide increases expression ISO IFI35 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of IFI35 protein CTD PMID:30501627 Ifi35 Rat lipopolysaccharide increases expression ISO Ifi35 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of IFI35 mRNA CTD PMID:22687549 and PMID:26582142 Ifi35 Rat lipopolysaccharide multiple interactions ISO Ifi35 (Mus musculus) 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA] CTD PMID:22687549 Ifi35 Rat methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of IFI35 mRNA CTD PMID:30467583 Ifi35 Rat methotrexate decreases expression ISO IFI35 (Homo sapiens) 6480464 Methotrexate results in decreased expression of IFI35 mRNA CTD PMID:19192274 Ifi35 Rat N-ethyl-N-nitrosourea increases mutagenesis ISO Ifi35 (Mus musculus) 6480464 Ethylnitrosourea results in increased mutagenesis of IFI35 gene CTD PMID:27776689 Ifi35 Rat N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of IFI35 mRNA CTD PMID:28801915 Ifi35 Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of IFI35 mRNA CTD PMID:24136188 Ifi35 Rat nickel atom decreases expression ISO IFI35 (Homo sapiens) 6480464 Nickel results in decreased expression of IFI35 mRNA CTD PMID:23195993 Ifi35 Rat nickel atom increases expression ISO IFI35 (Homo sapiens) 6480464 Nickel results in increased expression of IFI35 mRNA CTD PMID:25583101 Ifi35 Rat Nutlin-3 multiple interactions ISO IFI35 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of IFI35 mRNA CTD PMID:38460933 Ifi35 Rat ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of IFI35 mRNA CTD PMID:22124623 Ifi35 Rat paracetamol affects expression ISO Ifi35 (Mus musculus) 6480464 Acetaminophen affects the expression of IFI35 mRNA CTD PMID:17562736 Ifi35 Rat pentachlorophenol increases expression ISO Ifi35 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of IFI35 mRNA CTD PMID:23892564 Ifi35 Rat perfluorooctanoic acid decreases expression ISO IFI35 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of IFI35 mRNA CTD PMID:37738295 Ifi35 Rat resveratrol multiple interactions ISO IFI35 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of IFI35 mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of IFI35 mRNA CTD PMID:23557933 Ifi35 Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of IFI35 mRNA CTD PMID:19013527 Ifi35 Rat selenium atom increases expression ISO IFI35 (Homo sapiens) 6480464 Selenium results in increased expression of IFI35 mRNA CTD PMID:19244175 Ifi35 Rat silver atom decreases expression ISO Ifi35 (Mus musculus) 6480464 Silver results in decreased expression of IFI35 mRNA CTD PMID:27131904 Ifi35 Rat silver(0) decreases expression ISO Ifi35 (Mus musculus) 6480464 Silver results in decreased expression of IFI35 mRNA CTD PMID:27131904 Ifi35 Rat sodium arsenite increases expression ISO IFI35 (Homo sapiens) 6480464 sodium arsenite results in increased expression of IFI35 mRNA CTD PMID:38568856 Ifi35 Rat sodium aurothiomalate decreases expression ISO IFI35 (Homo sapiens) 6480464 Gold Sodium Thiomalate results in decreased expression of IFI35 mRNA CTD PMID:19192274 Ifi35 Rat sodium dodecyl sulfate decreases expression ISO IFI35 (Homo sapiens) 6480464 Sodium Dodecyl Sulfate results in decreased expression of IFI35 mRNA CTD PMID:31734321 Ifi35 Rat sotorasib multiple interactions ISO IFI35 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IFI35 mRNA CTD PMID:36139627 Ifi35 Rat stigmasterol decreases expression ISO Ifi35 (Mus musculus) 6480464 Stigmasterol results in decreased expression of IFI35 mRNA CTD PMID:30245210 Ifi35 Rat succimer multiple interactions ISO Ifi35 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI35 mRNA CTD PMID:21641980 Ifi35 Rat tamibarotene increases expression ISO IFI35 (Homo sapiens) 6480464 tamibarotene results in increased expression of IFI35 mRNA CTD PMID:15498508 Ifi35 Rat tamoxifen affects expression ISO Ifi35 (Mus musculus) 6480464 Tamoxifen affects the expression of IFI35 mRNA CTD PMID:20937368 Ifi35 Rat temozolomide increases expression ISO IFI35 (Homo sapiens) 6480464 Temozolomide results in increased expression of IFI35 mRNA CTD PMID:31758290 Ifi35 Rat tert-butyl hydroperoxide decreases expression ISO IFI35 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of IFI35 mRNA CTD PMID:15336504 Ifi35 Rat testosterone multiple interactions ISO IFI35 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of IFI35 mRNA CTD PMID:21592394 Ifi35 Rat testosterone increases expression ISO IFI35 (Homo sapiens) 6480464 Testosterone results in increased expression of IFI35 mRNA CTD PMID:21592394 Ifi35 Rat tetrachloroethene decreases expression ISO Ifi35 (Mus musculus) 6480464 Tetrachloroethylene results in decreased expression of IFI35 mRNA CTD PMID:28973375 Ifi35 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of IFI35 mRNA CTD PMID:31150632 Ifi35 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IFI35 mRNA] CTD PMID:31150632 Ifi35 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of IFI35 mRNA CTD PMID:23411599 and PMID:34492290 Ifi35 Rat tofacitinib decreases expression ISO IFI35 (Homo sapiens) 6480464 tofacitinib results in decreased expression of IFI35 mRNA CTD PMID:25487280 Ifi35 Rat trametinib multiple interactions ISO IFI35 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IFI35 mRNA CTD PMID:36139627 Ifi35 Rat triclosan increases expression ISO IFI35 (Homo sapiens) 6480464 Triclosan results in increased expression of IFI35 mRNA CTD PMID:30510588 Ifi35 Rat triphenyl phosphate affects expression ISO IFI35 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of IFI35 mRNA CTD PMID:37042841 Ifi35 Rat trovafloxacin increases expression ISO Ifi35 (Mus musculus) 6480464 trovafloxacin results in increased expression of IFI35 mRNA CTD PMID:35537566 Ifi35 Rat urethane decreases expression ISO IFI35 (Homo sapiens) 6480464 Urethane results in decreased expression of IFI35 mRNA CTD PMID:28818685 Ifi35 Rat valproic acid decreases expression ISO IFI35 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of IFI35 mRNA CTD PMID:29154799 Ifi35 Rat vancomycin decreases expression ISO Ifi35 (Mus musculus) 6480464 Vancomycin results in decreased expression of IFI35 mRNA CTD PMID:18930951 Ifi35 Rat vitamin E increases expression ISO IFI35 (Homo sapiens) 6480464 Vitamin E results in increased expression of IFI35 mRNA CTD PMID:19244175 Ifi35 Rat zidovudine multiple interactions ISO IFI35 (Homo sapiens) 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI35 mRNA CTD PMID:20370541
(+)-schisandrin B (EXP) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 4,4'-sulfonyldiphenol (ISO) 5-fluorouracil (ISO) 6alpha-methylprednisolone (ISO) actinomycin D (ISO) all-trans-retinoic acid (ISO) aluminium atom (ISO) aluminium(0) (ISO) aristolochic acid A (ISO) azathioprine (ISO) benzo[a]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) calcitriol (ISO) camptothecin (ISO) carbon nanotube (ISO) chlordecone (ISO) chromium(6+) (ISO) cisplatin (ISO) cyclosporin A (ISO) dibutyl phthalate (EXP) diclofenac (ISO) dieldrin (EXP) dioxygen (EXP) doxorubicin (ISO) elemental selenium (ISO) ethyl methanesulfonate (ISO) folic acid (ISO) Genipin (ISO) glycidyl methacrylate (ISO) isotretinoin (ISO) ivermectin (ISO) lead diacetate (ISO) lipopolysaccharide (ISO) methapyrilene (EXP) methotrexate (ISO) N-ethyl-N-nitrosourea (ISO) N-methyl-4-phenylpyridinium (EXP) nefazodone (EXP) nickel atom (ISO) Nutlin-3 (ISO) ochratoxin A (EXP) paracetamol (ISO) pentachlorophenol (ISO) perfluorooctanoic acid (ISO) resveratrol (ISO) rotenone (EXP) selenium atom (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sodium aurothiomalate (ISO) sodium dodecyl sulfate (ISO) sotorasib (ISO) stigmasterol (ISO) succimer (ISO) tamibarotene (ISO) tamoxifen (ISO) temozolomide (ISO) tert-butyl hydroperoxide (ISO) testosterone (ISO) tetrachloroethene (ISO) tetrachloromethane (EXP) thioacetamide (EXP) tofacitinib (ISO) trametinib (ISO) triclosan (ISO) triphenyl phosphate (ISO) trovafloxacin (ISO) urethane (ISO) valproic acid (ISO) vancomycin (ISO) vitamin E (ISO) zidovudine (ISO)
Ifi35 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 86,881,270 - 86,889,523 (+) NCBI GRCr8 mRatBN7.2 10 86,381,023 - 86,389,279 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 86,381,010 - 86,389,952 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 91,418,433 - 91,426,447 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 90,893,398 - 90,901,717 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 86,286,702 - 86,295,023 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 89,358,376 - 89,366,628 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 89,358,376 - 89,366,626 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 89,156,392 - 89,164,644 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 90,475,323 - 90,483,575 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 90,489,692 - 90,497,943 (+) NCBI Celera 10 85,098,510 - 85,106,762 (+) NCBI Celera Cytogenetic Map 10 q31 NCBI
IFI35 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 43,006,784 - 43,014,456 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 43,006,740 - 43,014,456 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 41,158,801 - 41,166,473 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 38,412,351 - 38,419,999 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 38,412,350 - 38,419,998 NCBI Celera 17 37,815,041 - 37,822,746 (+) NCBI Celera Cytogenetic Map 17 q21.31 NCBI HuRef 17 36,924,506 - 36,932,236 (+) NCBI HuRef CHM1_1 17 41,394,259 - 41,402,019 (+) NCBI CHM1_1 T2T-CHM13v2.0 17 43,864,072 - 43,871,742 (+) NCBI T2T-CHM13v2.0
Ifi35 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 101,339,238 - 101,349,527 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 101,339,233 - 101,349,524 (+) Ensembl GRCm39 Ensembl GRCm38 11 101,448,412 - 101,458,701 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 101,448,407 - 101,458,698 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 101,309,726 - 101,320,015 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 101,264,571 - 101,274,552 (+) NCBI MGSCv36 mm8 Celera 11 113,135,844 - 113,146,133 (+) NCBI Celera Cytogenetic Map 11 D NCBI cM Map 11 65.07 NCBI
Ifi35 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955451 16,790,383 - 16,802,664 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955451 16,790,998 - 16,798,993 (+) NCBI ChiLan1.0 ChiLan1.0
IFI35 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 21,977,994 - 21,985,622 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 23,867,276 - 23,874,824 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 14,310,106 - 14,317,648 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 14,539,625 - 14,544,931 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 14,539,625 - 14,544,931 (-) Ensembl panpan1.1 panPan2
IFI35 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 9 20,050,438 - 20,061,346 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 9 20,050,438 - 20,061,319 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 9 19,512,038 - 19,522,948 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 20,768,845 - 20,779,755 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 20,768,851 - 20,779,732 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 19,553,944 - 19,564,859 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 19,820,685 - 19,831,593 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 19,922,745 - 19,933,656 (-) NCBI UU_Cfam_GSD_1.0
Ifi35 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405602 19,364,845 - 19,367,164 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936490 17,708,071 - 17,713,492 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936490 17,707,997 - 17,710,294 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
IFI35 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 12 19,879,387 - 19,890,314 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 12 19,879,386 - 19,890,330 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 12 19,991,296 - 20,002,226 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
IFI35 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 16 63,276,493 - 63,284,196 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 16 63,273,829 - 63,284,283 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666077 34,063,175 - 34,070,917 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Ifi35
.
Predicted Target Of
Count of predictions: 74 Count of miRNA genes: 66 Interacting mature miRNAs: 70 Transcripts: ENSRNOT00000028067 Prediction methods: Microtar, Rnahybrid, Targetscan Result types: miRGate_prediction
1549846 Scl47 Serum cholesterol level QTL 47 3.6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 50574707 95574707 Rat 1298069 Bp168 Blood pressure QTL 168 5.5 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 10 26521957 98003205 Rat 61449 Ciaa2 CIA Autoantibody QTL 2 7.1 blood autoantibody amount (VT:0003725) calculated serum anti-type 2 collagen antibody titer (CMO:0001279) 10 63221094 107211142 Rat 631555 Bp134 Blood pressure QTL 134 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 80515287 91230079 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 1549831 Bss6 Bone structure and strength QTL 6 4 lumbar vertebra strength trait (VT:0010574) vertebra ultimate force (CMO:0001678) 10 57576521 102576521 Rat 70164 Bw21 Body weight QTL 21 4.36 0.00005 body mass (VT:0001259) body weight (CMO:0000012) 10 53797494 98952626 Rat 4889948 Bss91 Bone structure and strength QTL 91 4 tibia area (VT:1000281) tibia midshaft total cross-sectional area (CMO:0001715) 10 82564856 92369470 Rat 2298548 Neuinf7 Neuroinflammation QTL 7 3.4 nervous system integrity trait (VT:0010566) spinal cord RT1-B protein level (CMO:0002132) 10 72224939 107211142 Rat 1579919 Bp281 Blood pressure QTL 281 0.01 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 74372084 94965338 Rat 1302404 Cia27 Collagen induced arthritis QTL 27 2.6 0.0045 joint integrity trait (VT:0010548) experimental arthritis severity measurement (CMO:0001459) 10 76452683 107211142 Rat 1300107 Rf18 Renal function QTL 18 3.41 urine output (VT:0003620) timed urine volume (CMO:0000260) 10 78775516 98279596 Rat 8694173 Bw149 Body weight QTL 149 4.38 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 10 44441699 89441699 Rat 2300218 Hpcl2 Hepatic cholesterol level QTL 2 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 45029650 95600334 Rat 2317754 Glom25 Glomerulus QTL 25 3.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 82685200 107211142 Rat 1554317 Bmd4 Bone mineral density QTL 4 9.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 19816042 99406971 Rat 70171 Cari1 Carrageenan-induced inflammation QTL 1 4.9 0.0005 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 10 53797385 107211142 Rat 10450495 Bp383 Blood pressure QTL 383 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 76246085 94965338 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2292617 Ept18 Estrogen-induced pituitary tumorigenesis QTL 18 3.9 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 10 73453136 96120911 Rat 2301967 Cm73 Cardiac mass QTL 73 4.55 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 14487011 89062041 Rat 2313103 Bss80 Bone structure and strength QTL 80 2 0.0001 tibia strength trait (VT:1000284) tibia midshaft endosteal cross-sectional area (CMO:0001716) 10 62057807 107057807 Rat 2293646 Bss25 Bone structure and strength QTL 25 10.96 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 10 69738412 107211142 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 70188 BpQTLcluster1 Blood pressure QTL cluster 1 4.864 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 42323132 87323132 Rat 2300172 Bmd57 Bone mineral density QTL 57 9.8 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 10 69738412 107211142 Rat 70193 Mcs7 Mammary carcinoma susceptibility QTL 7 2.38 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 10 72224939 107211142 Rat 2313105 Bss79 Bone structure and strength QTL 79 1.8 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 10 62057807 107057807 Rat 9589030 Epfw9 Epididymal fat weight QTL 9 19.24 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 10 44441699 89441699 Rat 1357344 Bp249 Blood pressure QTL 249 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 66743655 98003205 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 70198 BpQTLcluster9 Blood pressure QTL cluster 9 2.94 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 42323132 87323132 Rat 2306970 Anxrr22 Anxiety related response QTL 22 5.95 fear/anxiety-related behavior trait (VT:1000241) number of periods of voluntary immobility (CMO:0001045) 10 61345276 98211570 Rat 1359017 Hrtrt21 Heart rate QTL 21 2.4 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 10 51772940 96772940 Rat 2293663 Bss33 Bone structure and strength QTL 33 9.34 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 10 69738412 107211142 Rat 7387312 Bw125 Body weight QTL 125 3 0.0047 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight (CMO:0000356) 10 64890616 107211142 Rat 2312672 Insul15 Insulin level QTL 15 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 10 57134272 102134272 Rat 6893357 Bw102 Body weight QTL 102 0.5 0.36 body mass (VT:0001259) body weight (CMO:0000012) 10 80515287 101325465 Rat 2317029 Aia19 Adjuvant induced arthritis QTL 19 2.98 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 66978955 107211142 Rat 2303589 Bw87 Body weight QTL 87 2 body mass (VT:0001259) body weight (CMO:0000012) 10 81285008 107211142 Rat 724556 Pur2 Proteinuria QTL 2 5.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 22427500 90627625 Rat 2306793 Ean5 Experimental allergic neuritis QTL 5 4.7 nervous system integrity trait (VT:0010566) IFNG-secreting splenocyte count (CMO:0002122) 10 72552416 93995749 Rat 61387 Bp1 Blood pressure QTL 1 5.1 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 51770177 107211142 Rat 2306792 Ean4 Experimental allergic neuritis QTL 4 4 nervous system integrity trait (VT:0010566) IFNG-secreting splenocyte count (CMO:0002122) 10 84022321 93995963 Rat 2317039 Aia6 Adjuvant induced arthritis QTL 6 4.31 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 66978955 107211142 Rat 61396 Bp9 Blood pressure QTL 9 4.8 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68420376 107211142 Rat 1358915 Stresp7 Stress response QTL 7 3.52 blood norepinephrine amount (VT:0005663) plasma norepinephrine level (CMO:0001010) 10 78899655 87307728 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 70364 Bp72 Blood pressure QTL 72 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 51121100 96121100 Rat 10450498 Bp384 Blood pressure QTL 384 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 67750049 107211142 Rat 4889492 Pancm2 Pancreatic morphology QTL 2 3.2 pancreatic beta cell morphology trait (VT:0005217) ratio of insulin-positive cell area to total area of splenic region of pancreas (CMO:0001814) 10 76748906 107211142 Rat 6893366 Bw106 Body weight QTL 106 0.3 0.47 body mass (VT:0001259) body weight (CMO:0000012) 10 70199100 107211142 Rat 2293698 Bss43 Bone structure and strength QTL 43 5.33 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 10 59209888 104209888 Rat 631530 Tls3 T-lymphoma susceptibility QTL 3 0 0.0001 thymus integrity trait (VT:0010555) percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911) 10 51774612 95600334 Rat 1354608 Cm33 Cardiac mass QTL 33 2.8 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 10 54809292 99809292 Rat 1558643 Cm44 Cardiac mass QTL 44 4.8 0.0000368 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 61345276 99703528 Rat 631535 Cm51 Cardiac mass QTL 51 3 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 10 51786282 91669536 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 7411614 Foco18 Food consumption QTL 18 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 44441699 89441699 Rat 6893336 Cm75 Cardiac mass QTL 75 0.1 0.87 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 61345276 99703528 Rat 631547 Bp87 Blood pressure QTL 87 4.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 47369470 92369470 Rat 61427 Cia16 Collagen induced arthritis QTL 16 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 6357896 96121100 Rat 12880055 Am11 Aortic mass QTL 11 0.004 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 10 84007272 95933025 Rat 2292438 Bp311 Blood pressure QTL 311 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 76246085 107211142 Rat 2312662 Slep8 Serum leptin concentration QTL 8 0.05 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 10 57134272 102134272 Rat 2301398 Kidm38 Kidney mass QTL 38 0.002 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 10 84007272 95933025 Rat 1600367 Mcs15 Mammary carcinoma susceptibility QTL 15 4.5 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 10 85565469 103884409 Rat 1358188 Ept9 Estrogen-induced pituitary tumorigenesis QTL 9 3.9 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 10 73453136 96120911 Rat 631537 Oia4 Oil induced arthritis QTL 4 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 75631887 87055282 Rat 1642980 Bp300 Blood pressure QTL 300 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68383129 107211142 Rat 631542 Bp82 Blood pressure QTL 82 6.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 26521957 98952741 Rat 2312668 Scl65 Serum cholesterol level QTL 65 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 57134272 102134272 Rat
RH135191
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 86,389,021 - 86,389,219 (+) MAPPER mRatBN7.2 Rnor_6.0 10 89,366,371 - 89,366,568 NCBI Rnor6.0 Rnor_5.0 10 89,164,387 - 89,164,584 UniSTS Rnor5.0 RGSC_v3.4 10 90,483,318 - 90,483,515 UniSTS RGSC3.4 Celera 10 85,106,505 - 85,106,702 UniSTS RH 3.4 Map 10 877.1 UniSTS Cytogenetic Map 10 q32.1 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000028067 ⟹ ENSRNOP00000028067
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 86,381,010 - 86,389,503 (+) Ensembl Rnor_6.0 Ensembl 10 89,358,376 - 89,366,626 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000101419 ⟹ ENSRNOP00000092407
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 86,381,010 - 86,389,952 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000117498 ⟹ ENSRNOP00000090927
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 86,386,878 - 86,389,503 (+) Ensembl
RefSeq Acc Id:
NM_001009625 ⟹ NP_001009625
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 86,881,270 - 86,889,523 (+) NCBI mRatBN7.2 10 86,381,023 - 86,389,279 (+) NCBI Rnor_6.0 10 89,358,376 - 89,366,628 (+) NCBI Rnor_5.0 10 89,156,392 - 89,164,644 (+) NCBI RGSC_v3.4 10 90,475,323 - 90,483,575 (+) RGD Celera 10 85,098,510 - 85,106,762 (+) RGD
Sequence:
GCAAGCAACAGCAGGGAAGTGAATTTCAGACACTGCTGGAGGCTGAGGAGACCAAAGCCACCTCTGACGGTTCAAATAAAAAGCTTTGGTCCCTCAGAACTCTACCCTTCCAGCCCTGCTCTGAAGCC
hide sequence
RefSeq Acc Id:
NP_001009625 ⟸ NM_001009625
- UniProtKB:
Q5M849 (UniProtKB/TrEMBL), F7FJL7 (UniProtKB/TrEMBL), A0A8I6ACU1 (UniProtKB/TrEMBL)
- Sequence:
MSVTLQAVLYSLQEEQSRLKTRLQELQQLKRERIDAPRDKIPFPVPEVPVVFQGLTKQSGQAPKSLVSNLKICCPLPGGSALITFDDPKVVERLLQQKEHKVDIEDCRLRVQIQPLELPMVTNIQVSS
hide sequence
Ensembl Acc Id:
ENSRNOP00000028067 ⟸ ENSRNOT00000028067
Ensembl Acc Id:
ENSRNOP00000092407 ⟸ ENSRNOT00000101419
Ensembl Acc Id:
ENSRNOP00000090927 ⟸ ENSRNOT00000117498
RGD ID: 13697761 Promoter ID: EPDNEW_R8286 Type: initiation region Name: Ifi35_1 Description: interferon-induced protein 35 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 10 89,358,403 - 89,358,463 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2005-12-06
Ifi35
interferon-induced protein 35
Ifi35_predicted
interferon-induced protein 35 (predicted)
Symbol and Name updated
1559027 APPROVED
2005-01-12
Ifi35_predicted
interferon-induced protein 35 (predicted)
Symbol and Name status set to approved
70820 APPROVED
